- Home
- MX vs IMUX Comparison
MX vs IMUX Comparison
Compare MX & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MX
- IMUX
- Stock Information
- Founded
- MX 2003
- IMUX 2016
- Country
- MX South Korea
- IMUX United States
- Employees
- MX N/A
- IMUX N/A
- Industry
- MX Semiconductors
- IMUX Biotechnology: Pharmaceutical Preparations
- Sector
- MX Technology
- IMUX Health Care
- Exchange
- MX Nasdaq
- IMUX Nasdaq
- Market Cap
- MX 103.8M
- IMUX 90.4M
- IPO Year
- MX N/A
- IMUX N/A
- Fundamental
- Price
- MX $3.24
- IMUX $0.83
- Analyst Decision
- MX Strong Buy
- IMUX Strong Buy
- Analyst Count
- MX 2
- IMUX 5
- Target Price
- MX $5.75
- IMUX $7.50
- AVG Volume (30 Days)
- MX 261.0K
- IMUX 1.3M
- Earning Date
- MX 10-29-2025
- IMUX 11-06-2025
- Dividend Yield
- MX N/A
- IMUX N/A
- EPS Growth
- MX N/A
- IMUX N/A
- EPS
- MX N/A
- IMUX N/A
- Revenue
- MX $234,243,000.00
- IMUX N/A
- Revenue This Year
- MX N/A
- IMUX N/A
- Revenue Next Year
- MX $7.05
- IMUX N/A
- P/E Ratio
- MX N/A
- IMUX N/A
- Revenue Growth
- MX 16.02
- IMUX N/A
- 52 Week Low
- MX $2.51
- IMUX $0.56
- 52 Week High
- MX $5.16
- IMUX $2.11
- Technical
- Relative Strength Index (RSI)
- MX 57.76
- IMUX 47.55
- Support Level
- MX $2.89
- IMUX $0.75
- Resistance Level
- MX $3.16
- IMUX $0.90
- Average True Range (ATR)
- MX 0.09
- IMUX 0.06
- MACD
- MX 0.05
- IMUX 0.00
- Stochastic Oscillator
- MX 95.89
- IMUX 56.34
About MX Magnachip Semiconductor Corporation
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely, Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.